Want to Participate in a Clinical Research Trial for OCD?

Fill out this quick Pre-Screening Questionnaire
  • Please complete this form to determine your eligibility for our OCD studies

Please enable JavaScript in your browser to complete this form.
Name
Please provide your legal name.

Please provide the best number to reach you, including the area code.

Please provide the best email to reach you.
Birth Date
Please provide your date of birth.

Please provide your zip code for location verification
Do you use recreational drugs including opioids and THC?
Are you comfortable taking an investigational medication daily as a part of the trial?
Are you currently taking an SSRI or SNRI?
Best Time and Date for us to reach you

Please let us know your preferred date and time for the call.
Expect a call from Excell Research Monday through Thursday between 8:30am and 6:00pm PT at 760-758-2222

https://excellresearch.com/wp-content/uploads/2023/07/Excell-Logo-New-Outlines@2x-1.png
Clinical Trial Studies

Pre-screening questionnaire and your privacy

Please be advised that by filling out the study pre-screening questionnaire, you will be asked to provide personal information, including age, gender, and your current medical condition. One of our staff will then reach out to conduct a phone-screen to see if you qualify for one of our current studies at our office location in Oceanside, CA. Your privacy is of the utmost importance to Excell Research. Your privacy will be protected and the information you provide will only be shared with those involved with the clinical research study if it is determined that you may be eligible to participate, unless you permit us to do so or except as required by law. Your information will not be sold to outside companies, nor will it be stored or collected without your direct consent.

Many pharmaceutical companies and Excell Research are conducting these studies under the Food and Drug Administration (FDA) to learn more about new investigational drugs or treatments. Read our privacy policy to learn more about how your information will be kept private.

OCD Clinical Research Studies Available

OCD Clinical Research Studies

Summary: OCD clinical trials investigate innovative treatments to help manage obsessive-compulsive disorder symptoms and improve daily functioning. Participants may access new therapies, receive expert care, and often receive compensation. Trials typically include assessments, therapy or medication regimens, and regular follow-ups with specialists. Eligibility varies, so interested individuals should contact trial coordinators to learn more.

Eligibility Criteria:

Key Inclusion Criteria:

  • Experiencing moderate to severe symptoms of obsessive-compulsive disorder in the past year.
  • Currently taking an SSRI medication for 8 weeks prior to study entry. (Zoloft, Prozac, Lexapro, Celexa, ect.)
  • Willing to stop exclusionary psychiatric medications prior to study entry.

Key Exclusion Criteria:

  • Lifetime history of bi-polar disorder, schizophrenia, borderline personality disorder or autism spectrum disorders.
  • Unwilling to discontinue exclusionary medications or comply with study procedures.
  • Any clinically significant unstable medical condition or any clinically significant chronic disease.

Patient Time Reimbursed?

Yes

Patient Travel Reimbursed?

Yes

Age:

18 to 65

Resources for Obsessive-Compulsive Disorder

Obsessive-Compulsive Disorder

Obsessive-compulsive disorder (OCD) features a pattern of unwanted thoughts and fears (obsessions) that lead you to do repetitive behaviors (compulsions). These obsessions and compulsions interfere with daily activities and cause significant distress.

Obsessions often have themes to them, such as:

  • Fear of contamination or dirt
  • Doubting and having difficulty tolerating uncertainty
  • Needing things orderly and symmetrical
  • Aggressive or horrific thoughts about losing control and harming yourself or others
  • Unwanted thoughts, including aggression, or sexual or religious subjects
https://excellresearch.com/wp-content/uploads/2024/06/4401749.jpg